In lab experiments with blood cells from psoriasis patients, CBD shifted immune responses from inflammatory Th1 toward anti-inflammatory Th2, boosted natural killer cell activity, and blocked inflammatory immune cell migration.
Dermatology researchers, people with psoriasis interested in cannabinoid research, and immunology researchers.
CBD modulated 5 different immune cell types simultaneously in psoriasis patient blood cells
What the researchers found
CBD shifted immune responses from Th1 to Th2, boosted NK cell cytotoxic activity, blocked monocyte migration in response to inflammatory stimuli, prevented full dendritic cell maturation, and promoted M2 (anti-inflammatory) macrophage polarization in PBMCs from psoriasis patients.
Why it matters
Psoriasis is driven by overactive immune responses in the skin. These results suggest CBD could address multiple immune pathways simultaneously, which is unusual for a single compound and could make it a versatile anti-inflammatory agent.
The numbers in context
CBD effects tested on: Th1/Th2 balance, NK cell cytotoxicity, monocyte migration, dendritic cell maturation, M2 macrophage polarization; all in psoriasis patient PBMCs
How the study worked
In vitro immune functional experiments testing CBD effects on various immune cell types (T cells, NK cells, monocytes, dendritic cells, macrophages) isolated from peripheral blood of individuals with psoriasis vulgaris.
What this study cannot tell us
In vitro study only. Immune cell behavior in a dish may not reflect what happens in living skin tissue. No clinical outcomes measured. The doses used may not be achievable in human skin.
How to read the evidence
In vitro study with no clinical component. Demonstrates biological plausibility but far from clinical evidence.
When this study was published
Published in 2024.
The bigger picture
Current psoriasis treatments often target single immune pathways. CBD's ability to modulate multiple immune cell types simultaneously could represent a new therapeutic approach, though these are lab findings that need clinical validation.
Questions still open
- Would topical CBD application produce similar immune-modulating effects in psoriatic skin lesions?
- Could CBD complement existing biologic therapies for psoriasis?
Common questions
Could CBD treat psoriasis?
How did CBD affect immune cells?
Read the original research
Cannabidiol exerts multitarget immunomodulatory effects on PBMCs from individuals with psoriasis vulgaris.
Frontiers in immunology, 15, 1373435
Citation
Pagano, Cristina; Ciaglia, Elena; Coppola, Laura; Lopardo, Valentina; Raimondo, Annunziata; Giuseppe, Monfrecola; Lembo, Serena; Laezza, Chiara; Bifulco, Maurizio. (2024). Cannabidiol exerts multitarget immunomodulatory effects on PBMCs from individuals with psoriasis vulgaris.. Frontiers in immunology, 15, 1373435. https://doi.org/10.3389/fimmu.2024.1373435
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk